Braintree Laboratories, Inc. is a fully integrated, privately held US-based multinational pharmaceutical company. From the start, the company has steadily established itself as a leader in specific niches of the pharmaceutical market. The company's prescription drugs are concentrated in the areas of Gastroenterology and Nephrology. Based on audited data, Braintree Laboratories leads the market in its products' classes.
Braintree Laboratories pioneered the first gastrointestinal lavage, GoLYTELY®, introducing it in 1984. In the 1990's, Braintree has introduced a new generation of gastrointestinal lavages, NuLYTELY® and Cherry Flavored NuLYTELY®. NuLYTELY is the fastest growing flavored GI lavage bowel prep and the #1 prescribed flavored bowel cleansing preparation in the U.S.A.
In February 1999, Braintree Laboratories received approval for MiraLax™, the first prescription laxative to clear the FDA in 23 years. U.S. marketing and sales have begun and are proceeding well.
In Nephrology, Braintree Laboratories markets the leader in phosphate binders, PhosLo®. This product assists patients with the kidney condition known as End Stage Renal Disease or ESRD.
In addition to its fully staffed R&D and manufacturing divisions, Braintree Laboratories maintains a national sales force.
Due to its success in these markets, Braintree seeks new business opportunities, both for licensing in and licensing out.
In the US, Braintree seeks licenses for products in gastroenterology, nephrology and other specialty area. Overseas, Braintree seeks partners for its products MiraLax™, NuLYTELY®, GoLYTELY®, and PhosLo®, which are described in greater detail in our web site www.braintreelabs.com.
For further information, please contact:
Russell W. Pelham, Ph.D.,
Director of Business Development
| Contact Details: |
| 60 Columbian St West |
| Braintree |
| MA |
| 02185 |
| United States of America |
| Tel: | 781 843 2202 |
| Fax: | 781-843-7932 |
| Email: | |
| WWW: | www.graylab.ac.uk/cancerweb/
|
|
Loading...
|
Recent Publications by Braintree Laboratories Incorporated: |  |
Safety of oral sulfates in rats and dogs contrasted with phosphate-induced nephropathy in rats.
An oral sulfate salt solution (OSS), under development as a bowel... | 19th August, 2009
| Braintree Laboratories Inc, 60 Columbian Street West, Braintree, MA 02185,
| Int J Toxicol. 2009 Mar-Apr;28(2):99-112.
DOI Direct Link |
Clinical trial: single- and multiple-dose pharmacokinetics of polyethylene glycol (PEG-3350) in healthy young and elderly subjects.
BACKGROUND: The pharmacokinetics of polyethylene glycol 3350 (PEG-3350)... | 14th October, 2008
| Braintree Laboratories Inc., Braintree, MA 02185, USA.
| Aliment Pharmacol Ther. 2008 Jul;28(2):256-65. Epub 2008 Apr 30.
DOI Direct Link |
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 935 times since April 2007, the link to the organisation's website has been followed 80 times
Recent Search Terms used to find this page: braintree patent laboritories | Braintree Laboratories | braintree laboratories | braintree laboratories | braintree laboratories | sulfate braintree patent | braintree laboratories incorporation | manufacturing companies in braintree | braintree oral sulfate | owner of braintree labs | .
Search for more companies in Braintree
Search for more companies in MA
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
Braintree Laboratories Incorporated
